Joseph Gathe - Concepedia

Author

Joseph Gathe

Also Known As

D. Fish, J GATHE, J Gallant, J Gathe, J. C. Gathe, J. Gathe, JOSEPH C. GATHE, Jeffrey Galpin, Joseph C Gathe, Joseph C. Gathe

105

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Gilead Sciences (United States)Orlando Immunology Center Research Triangle Park Foundation Johns Hopkins University University of North Carolina at Chapel Hill

About

Joseph Gathe is an author at Gilead Sciences (United States) specializing in medicine, hiv, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	1.6K
2	Engineering	1	1	79
3	Natural Sciences	1	1	79
4	Public Health	1	1	26
5	Chemistry	1	1	79

Joseph Gathe

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1 David Wyles, Peter Ruane, Mark Sulkowski, New England Journal of Medicine	2015	418
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial Edwin DeJesus, Jürgen K. Rockstroh, Keith Henry, The Lancet Hiv/aids CounsellingTreatment And PreventionMedicineAntiviral Drug DevelopmentClinical Trials	2012	346
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial Joseph J. Eron, Patrick Yéni, Joseph Gathe, The Lancet Klean StudyTreatment And PreventionHiv InfectionClinical TrialsAntiviral Drug Development	2006	341
Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1 Mark Sulkowski, Joseph J. Eron, David Wyles, JAMA	2015	305
SOLO Joseph Gathe, Prudence Ive, Robin Wood, AIDS	2004	196
Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment Anton Pozniak, José Ramón Arribas, Joseph Gathe, JAIDS Journal of Acquired Immune Deficiency Syndromes	2015	184
A Randomized, Double‐Blind, Placebo‐Controlled Trial of Cidofovir Gel for the Treatment of Acyclovir‐Unresponsive Mucocutaneous Herpes Simplex Virus Infection in Patients with AIDS Jacob Lalezari, Tim Schacker, Judith Feinberg, The Journal of Infectious Diseases	1997	161
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy Anthony Mills, Gordon Crofoot, Cheryl McDonald, JAIDS Journal of Acquired Immune Deficiency Syndromes	2015	139
Lopinavir/Ritonavir Combined with Raltegravir or Tenofovir/Emtricitabine in Antiretroviral-Naive Subjects: 96-Week Results of the PROGRESS Study Jacques Reynes, Roger Trinh, Federico Pulido, AIDS Research and Human Retroviruses Antiretroviral-naive SubjectsWeek 96Human RetrovirusImmunologyClinical Trials	2012	129
A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and Tenofovir DF for Initial Treatment of HIV-1 Infection Jürgen K. Rockstroh, Edwin DeJesus, Keith Henry, JAIDS Journal of Acquired Immune Deficiency Syndromes Week 48PharmacotherapyAntiviral DrugLogistic AnalysisAdverse Drug Reaction	2013	124

Page 1